Awarded
Suministro de medicamentos exclusivos: suministro de medicamentos exclusivos Brolucizumab (BEOVU), Everolimus (VOTUBIA), Inclisiran (LEQVIO), Ceritinib (ZYKADIA) y Asciminib (SCEMBLIX) y Gozetotida 68GA (LOCAMETZ).
Original language: Spanish
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- NOVARTIS FARMACEÚTICA, S.A
- Contract value
- €840,866
- Bids received
- 1
- Published
- 8 Sept 2026
- Awarded
- 27 May 2026
- Contract start
- 27 May 2026
- Contract end
- 14 Jun 2027estimated
- Region
- Madrid